Adaptive dose-finding designs to identify multiple doses that achieve multiple response targets

Documenti analoghi

• Simulation work in adaptive dose-finding designs to identify dose-intervals that achieve targets in multiple endpoints
  di: Howlett, James, et al.
  Pubblicazione: (2015)
• Rationale and study design of the Adaptive study of IL-2 dose on regulatory T cells in type 1 diabetes (DILT1D): a non-randomised, open label, adaptive dose finding trial
  di: Waldron-Lynch, Frank, et al.
  Pubblicazione: (2014)
• Protocol of the adaptive study of IL-2 dose frequency on regulatory T cells in type 1 diabetes (DILfrequency): a mechanistic, non-randomised, repeat dose, open-label, response-adaptive study
  di: Truman, Lucy A, et al.
  Pubblicazione: (2015)
• The DILfrequency study is an adaptive trial to identify optimal IL-2 dosing in patients with type 1 diabetes
  di: Seelig, Eleonora, et al.
  Pubblicazione: (2018)
• Adaptive enrichment in biomarker-stratified clinical trial design
  di: Parashar, Deepak, et al.
  Pubblicazione: (2013)